Reduction of Approval Time – Kaizen Institute India

8

description

In this documentation we are demonstrating how to Decrease the Approval Time for Vials (IP Stage) to 3 days from sterility launch day. To discover more information go to: http://in.kaizen.com/

Transcript of Reduction of Approval Time – Kaizen Institute India

  • Welcome To Kaizen Institute

  • Concerns / Issues Needing Attention

    Preliminary Objectives

    Current Situation & Target

    To Reduce the Approval time for Vials ( IP stage) to 3 days from sterility release date

    Company Name:

    BIOCON LTD

    Gemba:

    QUALITY ASSURANCE

    GKW Dates:

    1st August TO 31st August

    Project Title: Reduction of Approval time

    There is a variation in Approval time for an average of 6 to 10 Days

    BMR receipt after sterility release date

    Delay in BMR receipt and BPR Review

    No Priority intimation received

    Team Name:B1FQA Members: (R-L)Nilang Mehta, Ajay Puranik, Prabhakar M D, Uma K S.

    A

    P

    D

    C

    0

    1

    2

    3

    4

    5

    1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35

    No

    Of

    Da

    ys

    IP Stage Approval time in days

    1. Background & Targets

  • 2. Data Collection & Analysis

    Concerns /

    Problems

    needing

    attention :

    1.Large

    variations in

    Batch

    Approval days.

    2.Average = 4.6

    Days

    3.Range 8 Days

    8

    3

    1

    3

    5

    4

    3

    4

    1

    0

    1

    2

    3

    4

    5

    6

    7

    8

    9

    1 2 3 4 5 6 7 8 9

    No

    Of B

    atc

    hes

    Approval Time ( Days) Only 37 % with in 3 days

  • 3. Before After Process Mapping

  • 4. Actions during GKW

    1. BMR Submission before

    Sterility release date.

    2. Weekly updates from QA

    to stake holders of all

    concerned departments

    3. Time taken for approval

    tracked internally by QA

    using a tracker.

    4. Priority changes received

    from SCM

    5. Average after actions

    =1.9 days 0

    2

    4

    6

    8

    10

    12

    14

    16

    18

    20

    1 day 2 day 3 day 4 day

    19

    7

    3

    6

    No

    Of

    Ba

    tch

    es

    Approval Time in Days

  • 4. Results & non monetary benefits

    6

    Control Point Before Kaizen Target After Kaizen

    % Improved

    One time Financial Benefit

    Annual Benefit (Money Value)

    % of Batches with in target 36 100 % 83%

    40%

    Av. Batch Approval days 4.6 Days 3 Days 1.9 Days

    59%

    Target vs Result Trend Graph Control Point Improved team work

    Non Monetary Benefits

    0

    1

    2

    3

    4

    5

    1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35

    No

    Of

    Da

    ys

  • 5. Monitoring through Gemba Graphs

    7

    Biocon- Gemba Source of Data

    frequency of updation 5th of every month KAIZEN PROGRESS REVIEW Year 2013 Location Biocon Park

    Objective Batch released in target date Target 3 days Good

    Gebma QA Owner Uma

    Mar-13 Apr-13 May-13 Jun-13 Jul-13 Aug-13 Sep-13 Oct-13 Nov-13 Dec-13 Jan-14 Feb-14 Mar-14 Apr-14

    5 5 3 3 2 2

    3 3 3 3 3 3 3 3 3 3 3 3 3 3

    0

    1

    1

    2

    2

    3

    3

    4

    4

    5

    5

    Mr.13 Apr.13 Mai.13 Jun.13 Jul.13 Aug.13 Sep.13 Okt.13 Nov.13 Dez.13 Jn.14 Feb.14 Mr.14 Apr.14

    Ba

    tch

    es

    wit

    h i

    n t

    arg

    et